Global Thought Leader and Entrepreneur Adds Tremendous Expertise in New Product Launches, International Expansion and Manufacturing VANCOUVER, BC / May 1, 2018 / CVR Medical Corp.  (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical”) is pleased to announce the addition of Mr. Wayne Hellman to its Board of Directors and appointment as Vice-Chairman.  Mr. Hellman will [...]

VANCOUVER, BC / April 16, 2018 / CVR Medical Corp.   CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces that it intends to complete a private placement financing for gross proceeds of up to $1,000,000 (the "Financing"), which is expected to consist of units, with each unit comprised of one common share and [...]

VANCOUVER, BC / April 10, 2018 / CVR Medical Corp.   CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") today announced that the temporary warrant exercise price amendment expired at the close of business on April 6, 2018 (the "Amendment"). An aggregate of 2,518,600 warrants originally issued in the February and April, 2017 private [...]

VANCOUVER, BC / March 19, 2018 / CVR Medical Corp. The press release that follows is re-issued due to a typographical error in the access code of the original release (issued on March 16, 2018 at 5:30 a.m. PST) whereby access code to the conference call scheduled for March 19, 2018 at 1:00 p.m. EST [...]

VANCOUVER, BC / March 16, 2018 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") today announced that it will temporarily reduce the exercise price of its outstanding 2017 warrants originally issued in February and April 2017 (the "2017 Warrants") from CAD $0.70 (the "Original Exercise Price") to CAD $0.40 [...]

VANCOUVER, BC / March 7, 2018 / CVR Medical Corp. (TSX.V: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) advisory staff member Dr. Phillip J. Bendick, PhD, has completed his second clinical report summarizing additional data collected from tertiary clinical trials for the Carotid Stenotic Scan (CSS) device. His report confirms the evaluation stated in the [...]

VANCOUVER, BC / February 27, 2018 / CVR Medical Corp. (TSX.V: CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) announces Internal Review Board (IRB) approval by The Cleveland Clinic, sanctioning CVR to conduct clinical trials using the Carotid Stenotic Scan (CSS) device. The trial will be overseen by Primary Investigator Dr. Heather Gornik, Medical Director of [...]

VANCOUVER, BC / February 20, 2018 / CVR Medical Corp. (TSX.V: CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) announces the launch of pivotal clinical trials beginning Monday March 5, 2018 for the Carotid Stenotic Scan (CSS) device. This anticipated milestone represents the final phase of clinical substantiation which CVR will use to support the upcoming [...]

VANCOUVER, BC / February 13, 2018 / CVR Medical Corp. (TSX.V: CVM.V) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical”) announces placement of two additional wireless Carotid Stenotic Scan (CSS) devices into clinical trials at historic Methodist Hospital, part of the Thomas Jefferson University Hospital System. This deployment will be combined with the three wireless CSS devices [...]